U.S. Research Roundup-Adobe, Braveheart Bio, CACI International
SPY•Summary of research actions
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
| * Adobe Inc ADBE.O: Jefferies raises target price to $285 from $230 | |
| * ATI Inc ATI.N: TD Cowen raises target price to $250 from $210 | |
| * Braveheart Bio Inc BRVE.O: Jefferies initiates coverage with buy rating | |
| * Braveheart Bio Inc BRVE.O: Jefferies initiates coverage with target price $48 | |
| * BRC Inc BRCC.N: D.A. Davidson adjusts target price to $25 from $2.5 to reflect 1-for-10 reverse stock split | |
| * CACI International Inc CACI.N: TD Cowen raises target price to $700 from $550 | |
| * Dollar Tree Inc DLTR.O: Piper Sandler raises target price to $121 from $114 | |
| * Honeywell Aerospace Inc HONA.O: TD Cowen cuts target price to $180 from $250 | |
| * Intercontinental Exchange Inc ICE.N: Jefferies raises target price to $189 from $171 | |
| * Protagonist Therapeutics Inc PTGX.O: Jefferies raises target price to $171 from $169 | |
| * Rubrik Inc RBRK.N: CIBC raises target price to $120 from $115 |
Wall Street analysts adjust ratings and targets on several U.S.-listed companies
Aug. 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Braveheart Bio and CACI International, on Monday.
Highlights
| * Adobe Inc ADBE.O: Jefferies raises target price to $285 from $230 | |
| * Braveheart Bio, Inc. BRVE.O: Jefferies initiates coverage with buy rating | |
| * CACI International Inc CACI.N: TD Cowen raises target price to $700 from $550 |
